wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q39372427-E49F2D01-7F7A-4A40-8D76-6A865CF59D3A
Q39372427-E49F2D01-7F7A-4A40-8D76-6A865CF59D3A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39372427-E49F2D01-7F7A-4A40-8D76-6A865CF59D3A
Pharmaceutically inhibiting polo-like kinase 1 exerts a broad anti-tumour activity in retinoblastoma cell lines.
P2860
Q39372427-E49F2D01-7F7A-4A40-8D76-6A865CF59D3A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39372427-E49F2D01-7F7A-4A40-8D76-6A865CF59D3A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d3ba108e6d1278c8c88cd88fc6ef96cd59ef49b0
P2860
Initial testing (stage 1) of the Polo-like kinase inhibitor volasertib (BI 6727), by the Pediatric Preclinical Testing Program.